NYSE · INDUSTRIAL ORGANIC CHEMICALS · LARGE CAP
Westlake Corporation WLK
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY12 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$11.2B
▼ 8.0% vs FY2024
Dividend streak
12 yrs
Raised every year since 2014
EPS · FY25
$-11.70
Dividend / sh · FY25
$2.11
Payout · FY25
-18%
ROE · FY25
-15.6%
Net margin · FY25
-13.5%
Dividend coverage
-5.5×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 11.2B
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 14 cents on every revenue dollar this year.
Per share
USD -11.70
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
-15.6%
Return on equity, FY2025
ROE
Operating margin-14.1%
Net margin-13.5%
Return on assets-7.4%
Each USD of equity lost 16 cents this year.
Returned to shareholders
USD 335.0M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 272.0M
Net buybacksUSD 63.0M
Share of profit-22.2%
Consecutive raises12 years
USD 272.0M in dividends and USD 63.0M in buybacks went back to shareholders in a year without profit.
Growth
+8.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−10.9%
+8.3%
+9.6%
+8.8%
Dividend / share
+17.3%
+14.7%
+11.8%
Returned to shareholders
+10.0%
+11.9%
+2.8%
+22.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 20.0B
total assets, end of FY2025
Total assetsUSD 20.0B
EquityUSD 8.8B
CashUSD 2.7B
Gross debtUSD 5.6B
Net debtUSD 2.9B
Current ratio2.24×
Net debt stands at 33% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
11.2
12.1
12.5
15.8
11.8
7.5
8.1
8.6
8.0
5.1
4.5
4.4
3.8
3.6
3.6
3.2
2.3
Operating income $B
−1.6
0.9
0.7
3.0
2.8
0.4
0.7
1.4
1.2
0.6
1.0
1.1
1.0
0.6
0.4
0.4
0.1
EBITDA $B
−0.4
2.0
1.8
4.1
3.6
1.2
1.4
2.0
1.8
1.0
1.2
1.3
1.1
0.8
0.6
0.5
0.2
Income tax $B
−0.1
0.3
0.2
0.6
0.6
−0.0
0.1
0.3
−0.3
0.1
0.3
0.4
0.3
0.2
0.1
0.1
0.0
Net income $B
−1.5
0.6
0.5
2.2
2.0
0.3
0.4
1.0
1.3
0.4
0.6
0.7
0.6
0.4
0.3
0.2
0.1
EPS, diluted $
−11.70
4.64
3.70
17.34
15.58
2.56
3.25
7.62
10.00
3.06
4.86
5.07
4.55
2.88
3.87
3.34
0.80
Dividend / sh $
2.11
2.05
1.71
1.31
1.14
1.06
1.02
0.92
0.80
0.74
0.69
0.58
0.41
2.14
0.27
0.24
0.22
Payout %
−18
44
46
8
7
42
31
12
8
24
14
11
9
74
7
7
27
ROE %
−15.6
5.8
4.7
25.1
28.8
5.5
7.4
19.0
31.1
11.8
20.9
25.5
28.5
21.3
15.9
15.9
4.1
Shares out B
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
66 of 66
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed